triiodothyronine has been researched along with zoledronic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Giagourta, I; Karga, H; Kassi, G; Katsichti, P; Papaioannou, G; Pardalakis, A; Triantaphyllopoulou, M; Zagoreou, A; Zerva, C | 1 |
1 review(s) available for triiodothyronine and zoledronic acid
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for triiodothyronine and zoledronic acid
| Article | Year |
|---|---|
Transient changes in thyroid functions tests after zoledronic acid infusion.
Topics: Bone Density Conservation Agents; C-Reactive Protein; Diphosphonates; Female; Humans; Hydrocortisone; Imidazoles; Interleukin-6; Linear Models; Middle Aged; Osteoporosis, Postmenopausal; Prospective Studies; Thyroid Function Tests; Thyroid Gland; Thyrotropin; Thyroxine; Triiodothyronine; Triiodothyronine, Reverse; Tumor Necrosis Factor-alpha; Zoledronic Acid | 2011 |